Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1966 Apr;45(4):481–492. doi: 10.1172/JCI105362

Benzothiadiazine suppression of insulin release from normal and abnormal islet tissue in man.

S S Fajans, J C Floyd Jr, R F Knopf, J Rull, E M Guntsche, J W Conn
PMCID: PMC292722  PMID: 4287058

Full text

PDF
481

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CHAZAN J. A., BOSHELL B. R. ETIOLOGICAL FACTORS IN THIAZIDE-INDUCED OR AGGRAVATED DIABETES MELLITUS. Diabetes. 1965 Mar;14:132–136. doi: 10.2337/diab.14.3.132. [DOI] [PubMed] [Google Scholar]
  2. Coore H. G., Randle P. J. Regulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro. Biochem J. 1964 Oct;93(1):66–78. doi: 10.1042/bj0930066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DOLLERY C. T., PENTECOST B. L., SAMAAN N. A. Drug-induced diabetes. Lancet. 1962 Oct 13;2(7259):735–737. doi: 10.1016/s0140-6736(62)90567-6. [DOI] [PubMed] [Google Scholar]
  4. DRASH A., WOLFF F. DRUG THERAPY IN LEUCINE-SENSITIVE HYPOGLYCEMIA. Metabolism. 1964 Jun;13:487–492. doi: 10.1016/0026-0495(64)90133-7. [DOI] [PubMed] [Google Scholar]
  5. ERNESTI M., MITCHELL M. L., RABEN M. S., GILBOA Y. CONTROL OF HYPOGLYCAEMIA WITH DIAZOXIDE AND HUMAN GROWTH HORMONE. Lancet. 1965 Mar 20;1(7386):628–630. doi: 10.1016/s0140-6736(65)91716-2. [DOI] [PubMed] [Google Scholar]
  6. FAJANS S. S., FLOYD J. C., Jr, KNOPF R. F., CONN J. W. A COMPARISON OF LEUCINE- AND ACETOACETATE-INDUCED HYPOGLYCEMIA IN MAN. J Clin Invest. 1964 Oct;43:2003–2008. doi: 10.1172/JCI105074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. FLOYD J. C., Jr, FAJANS S. S., KNOPF R. F., CONN J. W. EVIDENCE THAT INSULIN RELEASE IS THE MECHANISM FOR EXPERIMENTALLY INDUCED LEUCINE HYPOGLYCEMIA IN MAN. J Clin Invest. 1963 Nov;42:1714–1719. doi: 10.1172/JCI104857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. FLOYD J. C., Jr, FAJANS S. S., KNOPF R. F., CONN J. W. PLASMA INSULIN IN ORGANIC HYPERINSULINISM: COMPARATIVE EFFECTS OF TOLBUTAMIDE, LEUCINE AND GLUCOSE. J Clin Endocrinol Metab. 1964 Aug;24:747–760. doi: 10.1210/jcem-24-8-747. [DOI] [PubMed] [Google Scholar]
  9. Fajans S. S., Knopf R. F., Floyd J. C., Power L., Conn J. W. THE EXPERIMENTAL INDUCTION IN MAN OF SENSITIVITY TO LEUCINE HYPOGLYCEMIA. J Clin Invest. 1963 Feb;42(2):216–229. doi: 10.1172/JCI104708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. KVAM D. C., STANTON H. C. STUDIES ON DIAZOXIDE HYPERGLYCEMIA. Diabetes. 1964 Nov-Dec;13:639–644. doi: 10.2337/diab.13.6.639. [DOI] [PubMed] [Google Scholar]
  11. OKUN R., RUSSELL R. P., WILSON W. R. USE OF DIAZOXIDE WITH TRICHLORMETHIAZIDE FOR HYPERTENSION. Arch Intern Med. 1963 Dec;112:882–888. [PubMed] [Google Scholar]
  12. RAPOPORT M. I., HURD H. F. THIAZIDE-INDUCED GLUCOSE INTOLERANCE TREATED WITH POTASSIUM. Arch Intern Med. 1964 Mar;113:405–408. doi: 10.1001/archinte.1964.00280090091014. [DOI] [PubMed] [Google Scholar]
  13. SAMAAN N., DOLLERY C. T., FRASER R. DIABETOGENIC ACTION OF BENZOTHIADIAZINES: SERUM-INSULIN-LIKE ACTIVITY IN DIABETES WORSENED OR PRECIPITATED BY THIAZIDE DIURETICS. Lancet. 1963 Dec 14;2(7320):1244–1246. doi: 10.1016/s0140-6736(63)90893-6. [DOI] [PubMed] [Google Scholar]
  14. STAQUET M., YABO R., VIKTORA J., WOLFF F. AN ADRENERGIC MECHANISM FOR HYPERGLYCEMIA INDUCED BY DIAZOXIDE. Metabolism. 1965 Sep;14:1000–1009. doi: 10.1016/0026-0495(65)90116-2. [DOI] [PubMed] [Google Scholar]
  15. TABACHNICK I. I., GULBENKIAN A., SEIDMAN F. THE EFFECT OF A BENZOTHIADIAZINE, DIAZOXIDE, ON CARBOHYDRATE METABOLISM. Diabetes. 1964 Jul-Aug;13:408–418. doi: 10.2337/diab.13.4.408. [DOI] [PubMed] [Google Scholar]
  16. WOLFF F. W. CLINICAL AND PHYSIOLOGICAL IMPLICATIONS OF DIABETES INDUCED BY BENZOTHIADIAZINES. Diabetes. 1964 Mar-Apr;13:203–205. doi: 10.2337/diab.13.2.203. [DOI] [PubMed] [Google Scholar]
  17. WOLFF F. W., LANGDON R. G. CONJOINT CLINIC ON DRUGS AND DIABETES. J Chronic Dis. 1964 Jul;17:585–596. doi: 10.1016/0021-9681(64)90082-7. [DOI] [PubMed] [Google Scholar]
  18. WOLFF F. W., LANGDON R. G., RUEBNER B. H., HOLLANDER C., SKOGLUND R. D. A NEW FORM OF EXPERIMENTAL DIABETES. Diabetes. 1963 Jul-Aug;12:335–338. doi: 10.2337/diab.12.4.335. [DOI] [PubMed] [Google Scholar]
  19. WOLFF F. W., PARMLEY W. W. Actiological factors in benzothiadiazine hyperglycemia. Lancet. 1963 Jul 13;2(7298):69–69. doi: 10.1016/s0140-6736(63)90066-7. [DOI] [PubMed] [Google Scholar]
  20. WOLFF F. W., PARMLEY W. W. FURTHER OBSERVATIONS CONCERNING THE HYPERGLYCEMIC ACTIVITY OF BENZOTHIADIAZINES. Diabetes. 1964 Mar-Apr;13:115–121. doi: 10.2337/diab.13.2.115. [DOI] [PubMed] [Google Scholar]
  21. WOLFF F. DIAZOXIDE HYPERGLYCAEMIA AND ITS CONTINUED RELIEF BY TOLBUTAMIDE. Lancet. 1964 Feb 8;1(7328):309–310. doi: 10.1016/s0140-6736(64)92414-6. [DOI] [PubMed] [Google Scholar]
  22. YALOW R. S., BERSON S. A. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960 Jul;39:1157–1175. doi: 10.1172/JCI104130. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES